Skip to main content

Bright Minds Biosciences Inc.

DRUG
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001827401

No open-market purchases or sales by Bright Minds Biosciences Inc. insiders were filed in the last 90 days; 99 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in Bright Minds Biosciences Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
99
+7 vs. Q1 2026
Shares held
9.31M
+1.41M (+17.8%) vs. Q1 2026
Total value
$653.8M
+$77.0M (+13.4%) vs. Q1 2026
New holders
19
47 more added
Sold out
12
17 more reduced

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DRUG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 99 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 9 institutionsQ1 2022: 11 institutionsQ2 2022: 10 institutionsQ3 2022: 14 institutionsQ4 2022: 9 institutionsQ1 2023: 9 institutionsQ2 2023: 8 institutionsQ3 2023: 6 institutionsQ4 2023: 8 institutionsQ1 2024: 7 institutionsQ2 2024: 6 institutionsQ3 2024: 6 institutionsQ4 2024: 31 institutionsQ1 2025: 34 institutionsQ2 2025: 47 institutionsQ3 2025: 64 institutionsQ4 2025: 74 institutionsQ1 2026: 94 institutionsQ2 2026: 99 institutions
Value heldQ2 2026: $653.8M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $2.93MQ1 2022: $628.0KQ2 2022: $399.0KQ3 2022: $509.0KQ4 2022: $309.6KQ1 2023: $256.7KQ2 2023: $326.3KQ3 2023: $309.2KQ4 2023: $329.8KQ1 2024: $255.6KQ2 2024: $208.2KQ3 2024: $229.8KQ4 2024: $176.4MQ1 2025: $188.4MQ2 2025: $137.0MQ3 2025: $366.1MQ4 2025: $514.9MQ1 2026: $670.3MQ2 2026: $653.8M
Institutions holding DRUG and their total value by quarter
QuarterHoldersValue
Q2 202699$653.8M
Q1 202694$670.3M
Q4 202574$514.9M
Q3 202564$366.1M
Q2 202547$137.0M
Q1 202534$188.4M
Q4 202431$176.4M
Q3 20246$229.8K
Q2 20246$208.2K
Q1 20247$255.6K
Q4 20238$329.8K
Q3 20236$309.2K
Q2 20238$326.3K
Q1 20239$256.7K
Q4 20229$309.6K
Q3 202214$509.0K
Q2 202210$399.0K
Q1 202211$628.0K
Q4 20219$2.93M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Bright Minds Biosciences Inc.; share changes are against Q1 2026.

Institutions holding DRUG in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
D. E. Shaw & Co., Inc.0$00.00%−15,445−100.0%Sold out
SEI Investments Co0$00.00%−11,188−100.0%Sold out
Ghisallo Capital Management LLC0$00.00%−11,000−100.0%Sold out
EAM Investors, LLC0$00.00%−9,189−100.0%Sold out
Quadrature Capital Ltd0$00.00%−6,498−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−3,141−100.0%Sold out
Virtu Financial LLC0$00.00%−3,129−100.0%Sold out
Persistent Asset Partners Ltd0$00.00%−2,310−100.0%Sold out
GWM Advisors LLC0$00.00%−250−100.0%Sold out
MAI Capital Management0$00.00%−1−100.0%Sold out
Twin Peaks Wealth Advisors, LLC0$00.00%−1−100.0%Sold out
Janus Henderson Group PLC––––Not filed
CWM, LLC––––Not filed